What does this research mean for the field?

Q: What does this research mean for the field?

A two-site Delfia immunoassay using monoclonal antibodies is a fast, sensitive, and reliable method for clinical measurements of the N-terminal peptide of pro-atrial natriuretic peptide (nANP). Novelty: ClaimNovelty.METHODOLOGICAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

January 1, 1997Upsala Journal of Medical SciencesOpen Access

A Two-site Delfia Immunoassay for Measurements of the N-terminal Peptide of pro-Atrial Natriuretic Peptide (nANP)

View Full Paper

Ask AI

Bookmark

Structured PICO

Population

100 healthy blood donors and 42 patients with different degrees of impaired renal function (total n=142).

Intervention

Two-site Delfia immunoassay using monoclonal antibodies for measuring the N-terminal peptide of pro-atrial natriuretic peptide (nANP).

Outcome

Assay performance (total assay variation) and reference interval determination.surrogate

The described two-site Delfia immunoassay provides a fast, sensitive, and reliable method for the clinical measurement of nANP.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

May support nANP assay use in research; leaves open clinical adoption pending validation studies.

Cite This Study

Stridsberg et al. (1997) studied this question.

synapsesocial.com/papers/6a1bec0626cb5670aa9d1d69 https://doi.org/10.3109/03009739709178934

View Full Paper

Ask AI

Bookmark

A Two-site Delfia Immunoassay for Measurements of the N-terminal Peptide of pro-Atrial Natriuretic Peptide (nANP)

Structured PICO

Discussion

Implication

Cite This Study

A Two-site Delfia Immunoassay for Measurements of the N-terminal Peptide of pro-Atrial Natriuretic Peptide (nANP)

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider